CD4 and cancer: The model was validated by bootstrap resampling.<h4>Results</h4>Cancer cell MHC I intensity, CD4+ T cell to tumour cell ratio, resection margin status and tumour T stage were identified for prediction model development using Cox proportional hazard regression.